Cargando…
Case of benralizumab‐induced exacerbations of chronic spontaneous urticaria
The role of IL‐5 in chronic spontaneous urticarial (CSU) is unclear. It may be that benralizumab is an important bidirectional modifier of CSU; that is, blocking IL‐5 may improve CSU in some patients, but it is possible that it may worsen CSU in others.
Autores principales: | Magen, Eli, Komarova, Irina, Magen, Israel, Phirtskhalava, Sofia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207228/ https://www.ncbi.nlm.nih.gov/pubmed/35765284 http://dx.doi.org/10.1002/ccr3.5930 |
Ejemplares similares
-
Recurrent spontaneous clearance of psoriasis during exacerbations of concomitant chronic spontaneous urticaria
por: Magen, Eli, et al.
Publicado: (2020) -
Symptomatic Secondary Selective IgM Immunodeficiency in Adult Man with Undiagnosed Celiac Disease
por: Magen, Eli, et al.
Publicado: (2012) -
Case Report: Acute effect of benralizumab on asthma exacerbation without concomitant corticosteroid use
por: Nolasco, Santi, et al.
Publicado: (2020) -
Hyperresponsiveness to antihistamines in spontaneous urticaria and heat urticaria
por: Durda, J., et al.
Publicado: (2017) -
Promising Effects of Benralizumab on Chronic Eosinophilic Pneumonia
por: Isomoto, Kohsuke, et al.
Publicado: (2020)